These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 5069481)

  • 1. [Action of catecholamines on the cardiovascular system under the effect of neuroleptoanalgesia].
    Montero Benzo R
    Rev Esp Anestesiol Reanim; 1972 Jul; 19(3):290-301. PubMed ID: 5069481
    [No Abstract]   [Full Text] [Related]  

  • 2. Potentiation of the cardiovascular effects of some catecholamines by a monoamine oxidase inhibitor.
    Cuthbert MF; Vere DW
    Br J Pharmacol; 1971 Oct; 43(2):471P-472P. PubMed ID: 5158241
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of drugs on the hemodynamics of the arterial and venous systems. II. Effects of norepinephrine and isoproterenol on arteriovenous circulation].
    Ikezono E; Aono M; Sawa K; Kakuta Y; Hattori Y
    Masui; 1970 Feb; 19(2):134-9. PubMed ID: 5461303
    [No Abstract]   [Full Text] [Related]  

  • 4. [Central hemodynamic indices and reactive properties of the cardiovascular system during neuroleptoanalgesia].
    Padalko VV
    Patol Fiziol Eksp Ter; 1979; (5):53-7. PubMed ID: 503581
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neuroleptoanalgesia].
    Gemperle M
    Aktuelle Probl Chir; 1970; 12():3-85. PubMed ID: 4146737
    [No Abstract]   [Full Text] [Related]  

  • 6. [Our experience with neuroleptoanalgesia, type II].
    Ciocatto E; Maritano M; Pattono R
    Acta Anaesthesiol; 1965; 16():Suppl 3:51-68. PubMed ID: 5899601
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evolution of neuroleptoanalgesia toward synaptoanalgesia].
    De Castro J; Gasparetto A; Giron G
    Acta Anaesthesiol; 1965; 16():Suppl 3:13-32. PubMed ID: 5899584
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo cardiovascular responses to isoproterenol, dopamine and tyramine after prolonged infusion of isoproterenol.
    Hayes JS; Pollock GD; Fuller RW
    J Pharmacol Exp Ther; 1984 Dec; 231(3):633-9. PubMed ID: 6094797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of rats. Part A.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):203-12. PubMed ID: 9861628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999).
    Aramendía P; Kaumann AJ
    J Pharmacol Exp Ther; 1967 Feb; 155(2):259-66. PubMed ID: 6025517
    [No Abstract]   [Full Text] [Related]  

  • 11. [Neuroleptoanalgesia].
    De Blasi A; Appiani L; Brienza A; Gasparetto A; Manni C; Maritano M; Mazzarella B; Morpurgo V
    Minerva Anestesiol; 1968 Aug; 34(8):933-90. PubMed ID: 5736580
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of treatment with dexamethasone on cardiovascular responses of adrenergic agents].
    Gorzalczany SB; Bramuglia GF; Tchercansky DM; Taira CA
    Acta Physiol Pharmacol Ther Latinoam; 1997; 47(1):1-8. PubMed ID: 9410222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Important side-effects of naloxone as an antagonist of neuroleptoanalgesia].
    Bigo P; Manno E; Matani A; Franco I
    Minerva Anestesiol; 1983 Jun; 49(6):389-91. PubMed ID: 6621900
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cardiac action of beta-blocking agents. V. Betasympatholytic activity of INPEA on the cardiovascular system].
    Poggioli R; Greggia A; Baiada A
    Boll Soc Ital Biol Sper; 1968 Aug; 44(16):1319-21. PubMed ID: 5732784
    [No Abstract]   [Full Text] [Related]  

  • 15. [Catecholamines and the vascular system].
    Stazka W
    Postepy Hig Med Dosw; 1971; 25(2):157-73. PubMed ID: 5575442
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacological research on 2-(2-isopropyl-phenoxy-methyl)imidazoline hydrochloride (phenoxazoline). I. Action on the cardiovascular system].
    Greggia A; Razzaboni G; Setti L; Tamiso R
    Boll Soc Ital Biol Sper; 1968 Jul; 44(13):1097-100. PubMed ID: 5727418
    [No Abstract]   [Full Text] [Related]  

  • 17. [Isoproterenol and cardiovascular reactivity in angina pectoris].
    Starcich R; Barbaresi F; Bacuzzi E; Pavarani A
    G Clin Med; 1966 Aug; 47(8):701-19. PubMed ID: 5989215
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship between the action of catecholamines and the pH of the environment].
    Abramets II; Komissarov IV
    Farmakol Toksikol; 1967; 30(5):580-4. PubMed ID: 5598920
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of some adrenergic blocking agents on cardiovascular system].
    Oka K
    Kumamoto Igakkai Zasshi; 1966 Oct; 40(10):1095-103. PubMed ID: 6013682
    [No Abstract]   [Full Text] [Related]  

  • 20. Interaction of cholecystokinin (CCK-33) and its C-terminal fragments: CCK-8 and CCK-4 with alpha- and beta-adrenoceptor agonists and antagonists in the cardiovascular system of diabetic rats. Part B.
    Wiśniewska RJ
    Pol J Pharmacol; 1998; 50(3):213-23. PubMed ID: 9861629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.